The pathophysiology of neuropsychiatric disorders, including depression, is linked to a disrupted serine/threonine kinase glycogen synthase kinase 3β (Akt/GSK3β signaling pathway) [18,19]. This evidence concerns the gene GSK3B and depressive symptom measurement.